EMBC

Embecta Corp. Common Stock (EMBC)

Stock · NASDAQ · Health Care

$5.05as of 8/28/2026

Active signals

Support level
$3.23
Industry
Medical/Dental Instruments

How Embecta Corp. Common Stock Makes Money

Where the revenue actually goes — FY2024 annual results

market-wall.comTotalRevenue$1.12BNet Income$78.30M (7%)Cost of Revenue$387.90M (35%)SG&A$365.10M (33%)Other$213.00M (19%)R&D$78.80M (7%)EMBC

Source: 10-K filed Dec 11, 2024 · via SEC EDGAR / Finnhub

Embecta Corp. Common Stock Competitors

Chosen by industry and closest market cap.

  • EMBC
    Embecta Corp. Common Stock
    $5.05
    ▲ 1.61%
    Market cap $207.65MP/E
  • PDEX
    Pro-Dex Inc. Common Stock
    $62.37
    ▼ 3.85%
    Market cap $209.06MP/E 17.93
    $23.47$69.86
  • LUCD
    Lucid Diagnostics Inc. Common Stock
    $0.9989
    ▲ 1.51%
    Market cap $193.54MP/E
    $0.8605$1.63
  • INFU
    InfuSystems Holdings Inc. Common Stock
    $12.06
    ▼ 0.00%
    Market cap $236.42MP/E
  • APYX
    Apyx Medical Corporation Common Stock
    $3.08
    ▲ 2.67%
    Market cap $174.35MP/E
    $1.7$5.08
  • KRMD
    KORU Medical Systems Inc. Common Stock (DE)
    $3.24
    ▲ 1.09%
    Market cap $163.52MP/E
    $3.21$6.61
  • CVRX
    CVRx Inc. Common Stock
    $2.95
    ▼ 3.12%
    Market cap $157.62MP/E

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
58.20M
Total value held
$489.15M
Institutional holders
330
Top holders this quarter
  • Unknown9.17M
  • Unknown3.67M
  • Unknown3.45M
  • Unknown3.44M
  • Unknown2.56M
  • Unknown2.55M
  • Unknown2.53M
  • Unknown2.36M
  • Unknown1.85M
  • Unknown1.59M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.